R Pg Family Wealth Advisory, LLC Blueprint Medicines Corp Transaction History

R Pg Family Wealth Advisory, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$84.1 - $120.5 $13,119 - $18,798	156 New	156 $14,000
Q2 2022 Aug 12, 2022	SELL	$45.23 - $70.15 $9,362 - $14,521	-207 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$82.78 - $101.0 $6,374 - $7,777	77 Added 59.23%	207 $18,000
Q2 2020 Aug 10, 2020	SELL	$57.09 - $79.27 $3,710 - $5,152	-65 Reduced 33.33%	130 $10,000
Q1 2020 May 14, 2020	SELL	$48.11 - $82.22 $2,453 - $4,193	-51 Reduced 20.73%	195 $11,000
Q4 2019 Feb 12, 2020	BUY	$66.73 - $82.59 $1,668 - $2,064	25 Added 11.31%	246 $19,000
Q1 2019 May 14, 2019	BUY	$48.7 - $86.6 $1,558 - $2,771	32 Added 16.93%	221 $0
Q3 2018 Nov 14, 2018	BUY	$58.91 - $78.32 $1,590 - $2,114	27 Added 16.67%	189 $0
Q3 2017 Nov 08, 2017	BUY	$42.37 - $69.67 $6,863 - $11,286	162	162 $0

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.47B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of R Pg Family Wealth Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on R Pg Family Wealth Advisory, LLC with notifications on news.